Reduced Compensatory β-Cell Proliferation in Nfatc3-Deficient Mice Fed on High-Fat Diet

Abstract

Background High-fat-diet induces pancreatic β-cell compensatory proliferation, and impairments in pancreatic β-cell proliferation and function can lead to defects in insulin secretion and diabetes. NFATc3 is important for HFD-induced adipose tissue inflammation. But it is unknown whether NFATc3 is required for β cell compensatory growth in mice fed with HFD.

Methods NFATc3 mRNA and protein expression levels were quantified by RT-qPCR and Western blotting, respectively, in pancreatic islets of WT mice fed on HFD for 12–20 weeks. Adenoviral-mediated overexpression of NFATc3 were conducted in Min6 cells and cultured primary mouse islets. NFATc3-/- mice and WT control mice were fed with HFD and metabolic and functional parameters were measured.

Results We observed that the NFATc3 expression level was reduced in the islets of high-fat-diet (HFD)-fed mice. Adenovirus-mediated overexpression of NFATc3 enhanced glucose-stimulated insulin secretion and β-cell gene expression in cultured primary mouse islets. Nfatc3-/- mice initially developed similar glucose tolerance at 2–4 weeks after HFD feeding than HFD-fed WT mice, but Nfatc3-/- mice developed improved glucose tolerance and insulin sensitivity after 8 weeks of HFD feeding compared to Nfatc3+/+fed with HFD. Furthermore, Nfatc3-/- mice on HFD exhibited decreased β-cell mass and reduced expression of genes important for β-cell proliferation and function compared to Nfatc3+/+mice on HFD.

Conclusions The findings suggested that NFATc3 plays a role in maintaining the pancreatic β-cell compensatory growth and gene expression in response to obesity.

Key words

Nfatc3 - pancreatic β-Cell - diabetes - high-fat diet

Publication History

Received: 17 March 2019
Received: 22 August 2019

Accepted: 03 September 2019

Article published online:
23 September 2019

• References

• 1 Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004; 53 Suppl 3 S16-S21
• 2 Weir GC, Laybutt DR, Kaneto H. et al. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 2001; 50 Suppl 1 S154-S159
• 3 Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr Diabetes Rev 2013; 9: 25-53
• 4 Kaneto H, Matsuoka TA. Role of pancreatic transcription factors in maintenance of mature beta-cell function. Int J Mol Sci 2015; 16: 6281-6297
• 5 Zhu Y, Liu Q, Zhou Z. et al. PDX1, Neurogenin-3, and MAFA: Critical transcription regulators for beta cell development and regeneration. Stem Cell Res Ther 2017; 8: 240
• 6 Ackermann AM, Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J Mol Endocrinol 2007; 38: 193-206
• 7 Talchai C, Xuan S, Lin HV. et al. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 2012; 150: 1223-1234
• 8 Gradwohl G, Dierich A, LeMeur M. et al. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000; 97: 1607-1611
• 9 Schaffer AE, Taylor BL, Benthuysen JR. et al. Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity. PLoS Genet 2013; 9: e1003274
• 10 Georgia S, Hinault C, Kawamori D. et al. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes 2010; 59: 987-996
• 11 Tschen SI, Zeng C, Field L. et al. Cyclin D2 is sufficient to drive beta cell self-renewal and regeneration. Cell Cycle 2017; 16: 2183-2191
• 12 Kushner JA, Ciemerych MA, Sicinska E. et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 2005; 25: 3752-3762
• 13 Stamateris RE, Sharma RB, Kong Y. et al. Glucose induces mouse beta-cell proliferation via IRS2, MTOR, and Cyclin D2 but not the insulin receptor. Diabetes 2016; 65: 981-995
• 14 Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15: 707-747
• 15 Oukka M, Ho IC, de la Brousse FC. et al. The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity 1998; 9: 295-304
• 16 Wilkins BJ, Dai YS, Bueno OF. et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 2004; 94: 110-118
• 17 Dai YS, Xu J, Molkentin JD. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol Cell Biol 2005; 25: 9936-9948
• 18 de Frutos S, Duling L, Alo D. et al. NFATc3 is required for intermittent hypoxia-induced hypertension. Am J Physiol Heart Circ Physiol 2008; 294: H2382-H2390
• 19 de Frutos S, Caldwell E, Nitta CH. et al. NFATc3 contributes to intermittent hypoxia-induced arterial remodeling in mice. Am J Physiol Heart Circ Physiol 2010; 299: H356-H363
• 20 Ranjan R, Deng J, Chung S. et al. The transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis. J Innate Immun 2014; 6: 754-764
• 21 Keller MP, Paul PK, Rabaglia ME. et al. The Transcription factor nfatc2 regulates beta-cell proliferation and genes associated with type 2 diabetes in mouse and human islets. PLoS Genet 2016; 12: e1006466
• 22 Dai C, Hang Y, Shostak A. et al. Age-dependent human beta cell proliferation induced by glucagon-like peptide 1 and calcineurin signaling. J Clin Invest 2017; 127: 3835-3844
• 23 Hu L, He F, Huang M. et al. NFATc3 Deficiency reduces the classical activation of adipose tissue macrophages. J Mol Endocrinol 2018; 61: 79-89
• 24 De Windt LJ, Lim HW, Taigen T. et al. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circ Res 2000; 86: 255-263
• 25 Luo Y, He F, Hu L. et al. Transcription factor Ets1 regulates expression of thioredoxin-interacting protein and inhibits insulin secretion in pancreatic beta-cells. PLoS One 2014; 9: e99049
• 26 Zhang J, Zhang N, Liu M. et al. Disruption of growth factor receptor-binding protein 10 in the pancreas enhances beta-cell proliferation and protects mice from streptozotocin-induced beta-cell apoptosis. Diabetes 2012; 61: 3189-3198
• 27 Heit JJ, Apelqvist AA, Gu X. et al. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006; 443: 345-349
• 28 Kim HS, Hwang YC, Koo SH. et al. PPAR-gamma activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic beta-cells. PLoS One 2013; 8: e50128
• 29 Ashcroft FM, Rorsman P. Diabetes mellitus and the beta cell: The last ten years. Cell 2012; 148: 1160-1171
• 30 Remizov O, Jakubov R, Dufer M. et al. Palmitate-induced Ca2+-signaling in pancreatic beta-cells. Mol Cell Endocrinol 2003; 212: 1-9
• 31 Ramadan JW, Steiner SR, O'Neill CM. et al. The central role of calcium in the effects of cytokines on beta-cell function: implications for type 1 and type 2 diabetes. Cell Calcium 2011; 50: 481-490
• 32 Demozay D, Tsunekawa S, Briaud I. et al. Specific glucose-induced control of insulin receptor substrate-2 expression is mediated via Ca2+-dependent calcineurin/NFAT signaling in primary pancreatic islet beta-cells. Diabetes 2011; 60: 2892-2902
• 33 Goodyer WR, Gu X, Liu Y. et al. Neonatal beta cell development in mice and humans is regulated by calcineurin/NFAT. Dev Cell 2012; 23: 21-34
• 34 Lawrence MC, Bhatt HS, Easom RA. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1. Diabetes 2002; 51: 691-698
• 35 Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005; 5: 472-484
• 36 Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA. et al. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr Rev 2006; 27: 356-370
• 37 Heit JJ, Karnik SK, Kim SK. Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 2006; 22: 311-338
• 38 Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol Cell Endocrinol 2008; 294: 1-9
• 39 Pierre KB, Jones CM, Pierce JM. et al. NFAT4 deficiency results in incomplete liver regeneration following partial hepatectomy. J Surg Res 2009; 154: 226-233
• 40 Long CJ, Butler S, Fesi J. et al. Genetic or pharmacologic disruption of the calcineurin-nuclear factor of activated T-cells axis prevents social stress-induced voiding dysfunction in a murine model. J Pediatr Urol 2014; 10: 598-604
• 41 Raum JC, Gerrish K, Artner I. et al. FoxA2, Nkx2.2, and PDX-1 regulate islet beta-cell-specific mafA expression through conserved sequences located between base pairs -8118 and -7750 upstream from the transcription start site. Mol Cell Biol 2006; 26: 5735-5743
• 42 Aramata S, Han SI, Kataoka K. Roles and regulation of transcription factor MafA in islet beta-cells. Endocr J 2007; 54: 659-666
• 43 Kitamura T, Ido Kitamura Y. Role of FoxO proteins in pancreatic beta cells. Endocr J 2007; 54: 507-515
• 44 Martin CC, Flemming BP, Wang Y. et al. Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression. J Mol Endocrinol 2008; 41: 315-328
• 45 Lawrence MC, McGlynn K, Park BH. et al. ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J Biol Chem 2005; 280: 26751-26759